» Articles » PMID: 29676998

An Epigenetic Biomarker of Aging for Lifespan and Healthspan

Abstract

Identifying reliable biomarkers of aging is a major goal in geroscience. While the first generation of epigenetic biomarkers of aging were developed using chronological age as a surrogate for biological age, we hypothesized that incorporation of composite clinical measures of phenotypic age that capture differences in lifespan and healthspan may identify novel CpGs and facilitate the development of a more powerful epigenetic biomarker of aging. Using an innovative two-step process, we develop a new epigenetic biomarker of aging, DNAm PhenoAge, that strongly outperforms previous measures in regards to predictions for a variety of aging outcomes, including all-cause mortality, cancers, healthspan, physical functioning, and Alzheimer's disease. While this biomarker was developed using data from whole blood, it correlates strongly with age in every tissue and cell tested. Based on an in-depth transcriptional analysis in sorted cells, we find that increased epigenetic, relative to chronological age, is associated with increased activation of pro-inflammatory and interferon pathways, and decreased activation of transcriptional/translational machinery, DNA damage response, and mitochondrial signatures. Overall, this single epigenetic biomarker of aging is able to capture risks for an array of diverse outcomes across multiple tissues and cells, and provide insight into important pathways in aging.

Citing Articles

A new robust AI/ML based model for accurate forensic age estimation using DNA methylation markers.

Mathew J, Paul G, Jacob J, Kumar J, Dubey N, Philip N Forensic Sci Med Pathol. 2025; .

PMID: 40085291 DOI: 10.1007/s12024-025-00985-x.


Biological age prediction and NAFLD risk assessment: a machine learning model based on a multicenter population in Nanchang, Jiangxi, China.

Deng L, Huang J, Yuan H, Liu Q, Lou W, Yu P BMC Gastroenterol. 2025; 25(1):172.

PMID: 40082778 PMC: 11908037. DOI: 10.1186/s12876-025-03752-y.


Epigenetic Landscapes of Aging in Breast Cancer Survivors: Unraveling the Impact of Therapeutic Interventions-A Scoping Review.

Nikita N, Sun Z, Sharma S, Shaver A, Seewaldt V, Lu-Yao G Cancers (Basel). 2025; 17(5).

PMID: 40075712 PMC: 11899678. DOI: 10.3390/cancers17050866.


Elevated urinary phytoestrogens are associated with delayed biological aging: a cross-sectional analysis of NHANES data.

Wang J, Cao Q, Gao M, Pan Y, Chen Y, Cao Y Sci Rep. 2025; 15(1):8587.

PMID: 40075117 PMC: 11904004. DOI: 10.1038/s41598-025-88872-x.


The association between gut microbiota and accelerated aging and frailty: a Mendelian randomization study.

Yan Z, Guan G, Jia H, Li H, Zhuoga S, Zheng S Aging Clin Exp Res. 2025; 37(1):82.

PMID: 40074999 PMC: 11903541. DOI: 10.1007/s40520-025-02971-3.


References
1.
Bocklandt S, Lin W, Sehl M, Sanchez F, Sinsheimer J, Horvath S . Epigenetic predictor of age. PLoS One. 2011; 6(6):e14821. PMC: 3120753. DOI: 10.1371/journal.pone.0014821. View

2.
Horvath S, Garagnani P, Bacalini M, Pirazzini C, Salvioli S, Gentilini D . Accelerated epigenetic aging in Down syndrome. Aging Cell. 2015; 14(3):491-5. PMC: 4406678. DOI: 10.1111/acel.12325. View

3.
Marioni R, Shah S, McRae A, Ritchie S, Muniz-Terrera G, Harris S . The epigenetic clock is correlated with physical and cognitive fitness in the Lothian Birth Cohort 1936. Int J Epidemiol. 2015; 44(4):1388-96. PMC: 4588858. DOI: 10.1093/ije/dyu277. View

4.
Garinis G, Uittenboogaard L, Stachelscheid H, Fousteri M, van IJcken W, Breit T . Persistent transcription-blocking DNA lesions trigger somatic growth attenuation associated with longevity. Nat Cell Biol. 2009; 11(5):604-15. PMC: 2782455. DOI: 10.1038/ncb1866. View

5.
Gonskikh Y, Polacek N . Alterations of the translation apparatus during aging and stress response. Mech Ageing Dev. 2017; 168:30-36. DOI: 10.1016/j.mad.2017.04.003. View